Want to see IN:SAKAR full AI Analyst Report?
Sakar Healthcare Ltd (SAKAR) Ratios
Sakar Healthcare Ltd Ratios
IN:SAKAR's free cash flow for Q2 2027 was $0.00. For the 2027 fiscal year, IN:SAKAR's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.28 | 1.40 | 1.21 | 1.03 | 1.07 |
| Quick Ratio | 0.64 | 0.71 | 0.74 | 0.74 | 0.77 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | 0.35 | 0.30 | 0.23 | 0.17 | 0.18 |
| Operating Cash Flow Ratio | 0.36 | 0.30 | 0.41 | 0.65 | 0.76 |
| Short-Term Operating Cash Flow Coverage | 1.64 | 0.88 | 1.00 | 1.69 | 4.54 |
| Net Current Asset Value | $ -160.98M | $ -410.58M | $ -547.15M | $ -1.07B | $ -902.76M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.18 | 0.20 | 0.35 | 0.35 |
| Debt-to-Equity Ratio | 0.17 | 0.26 | 0.30 | 0.69 | 0.73 |
| Debt-to-Capital Ratio | 0.15 | 0.21 | 0.23 | 0.41 | 0.42 |
| Long-Term Debt-to-Capital Ratio | 0.09 | 0.16 | 0.17 | 0.36 | 0.40 |
| Financial Leverage Ratio | 1.48 | 1.45 | 1.48 | 1.94 | 2.10 |
| Debt Service Coverage Ratio | 1.95 | 1.57 | 1.10 | 1.25 | 2.59 |
| Interest Coverage Ratio | 5.77 | 3.37 | 6.53 | 3.10 | 13.42 |
| Debt to Market Cap | 0.05 | 0.15 | 0.10 | 0.32 | 1.08 |
| Interest Debt Per Share | 28.38 | 38.31 | 42.36 | 67.30 | 63.52 |
| Net Debt to EBITDA | 0.77 | 1.47 | 2.01 | 3.15 | 2.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 26.29% | 24.10% | 45.38% | 44.85% | 41.65% |
| EBIT Margin | 18.91% | 16.93% | 13.86% | 17.12% | 16.09% |
| EBITDA Margin | 28.27% | 28.69% | 25.51% | 28.35% | 24.62% |
| Operating Profit Margin | 18.00% | 16.22% | 32.14% | 13.84% | 30.33% |
| Pretax Profit Margin | 15.79% | 12.12% | 10.31% | 12.65% | 14.76% |
| Net Profit Margin | 12.11% | 9.86% | 7.57% | 9.57% | 11.89% |
| Continuous Operations Profit Margin | 12.11% | 9.86% | 7.57% | 9.57% | 11.89% |
| Net Income Per EBT | 76.68% | 81.30% | 73.40% | 75.60% | 80.51% |
| EBT Per EBIT | 87.71% | 74.74% | 32.09% | 91.43% | 48.69% |
| Return on Assets (ROA) | 6.34% | 4.21% | 3.00% | 3.79% | 5.69% |
| Return on Equity (ROE) | 9.40% | 6.13% | 4.45% | 7.36% | 11.96% |
| Return on Capital Employed (ROCE) | 12.20% | 8.18% | 15.03% | 6.55% | 17.60% |
| Return on Invested Capital (ROIC) | 8.79% | 6.27% | 10.27% | 4.61% | 13.62% |
| Return on Tangible Assets | 6.44% | 4.26% | 3.01% | 3.79% | 5.69% |
| Earnings Yield | 2.75% | 3.42% | 1.52% | 3.42% | 17.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.03 | 5.78 | 7.37 | 6.04 | 9.04 |
| Payables Turnover | 3.60 | 6.40 | 3.07 | 2.82 | 2.87 |
| Inventory Turnover | 2.65 | 3.09 | 3.00 | 4.78 | 5.27 |
| Fixed Asset Turnover | 0.78 | 0.55 | 0.49 | 0.49 | 0.59 |
| Asset Turnover | 0.52 | 0.43 | 0.40 | 0.40 | 0.48 |
| Working Capital Turnover Ratio | 8.92 | 9.32 | 22.06 | 56.92 | 69.01 |
| Cash Conversion Cycle | 109.01 | 124.14 | 52.18 | 7.37 | -17.71 |
| Days of Sales Outstanding | 72.62 | 63.15 | 49.54 | 60.42 | 40.37 |
| Days of Inventory Outstanding | 137.77 | 118.04 | 121.64 | 76.42 | 69.20 |
| Days of Payables Outstanding | 101.38 | 57.05 | 119.00 | 129.47 | 127.28 |
| Operating Cycle | 210.39 | 181.19 | 171.17 | 136.84 | 109.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 17.69 | 8.60 | 11.92 | 18.99 | 23.68 |
| Free Cash Flow Per Share | 4.95 | -6.22 | -17.10 | -25.21 | -41.01 |
| Dividend Paid and CapEx Coverage Ratio | 1.39 | 0.58 | 0.41 | 0.43 | 0.37 |
| Capital Expenditure Coverage Ratio | 1.39 | 0.58 | 0.41 | 0.43 | 0.37 |
| Operating Cash Flow Coverage Ratio | 0.71 | 0.25 | 0.31 | 0.30 | 0.38 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.11 | 0.16 | 0.26 | 0.28 |
| Free Cash Flow Yield | 0.99% | -2.65% | -4.58% | -12.57% | -72.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 36.38 | 29.24 | 65.68 | 29.23 | 5.63 |
| Price-to-Sales (P/S) Ratio | 4.41 | 2.88 | 4.97 | 2.80 | 0.67 |
| Price-to-Book (P/B) Ratio | 3.42 | 1.79 | 2.92 | 2.15 | 0.67 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 100.66 | -37.75 | -21.84 | -7.96 | -1.39 |
| Price-to-Operating Cash Flow Ratio | 28.17 | 27.31 | 31.33 | 10.56 | 2.40 |
| Price-to-Earnings Growth (PEG) Ratio | 0.52 | 0.71 | -3.85 | -0.91 | 0.13 |
| Enterprise Value Multiple | 16.36 | 11.51 | 21.50 | 13.01 | 5.66 |
| Enterprise Value | 11.64B | 5.86B | 8.46B | 4.92B | 1.79B |
| EV to EBITDA | 16.36 | 11.51 | 21.50 | 13.01 | 5.66 |
| EV to Sales | 4.62 | 3.30 | 5.48 | 3.69 | 1.39 |
| EV to Free Cash Flow | 105.66 | -43.26 | -24.10 | -10.50 | -2.89 |
| EV to Operating Cash Flow | 29.57 | 31.30 | 34.56 | 13.93 | 5.00 |
| Tangible Book Value Per Share | 142.47 | 128.89 | 127.10 | 93.23 | 84.55 |
| Shareholders’ Equity Per Share | 145.81 | 131.00 | 127.81 | 93.23 | 84.55 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.19 | 0.27 | 0.24 | 0.20 |
| Revenue Per Share | 113.13 | 81.49 | 75.11 | 71.73 | 85.05 |
| Net Income Per Share | 13.70 | 8.03 | 5.69 | 6.86 | 10.11 |
| Tax Burden | 0.77 | 0.81 | 0.73 | 0.76 | 0.81 |
| Interest Burden | 0.83 | 0.72 | 0.74 | 0.74 | 0.92 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| SG&A to Revenue | 0.08 | 0.08 | 0.13 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.29 | 1.07 | 2.10 | 2.09 | 1.89 |
Currency in INR
